CITI-Sci Series: 10.07.26 "Idea to Impact: IP Strategy for Societal Benefit"

Micheal Dixon

President and CEO

Unemed Corporation

Michael Dixon is president and CEO of the UNeMed Corporation, where he is responsible for setting UNeMed’s strategic path and directing UNeMed’sactivities; including efforts to protect, market, and license new technology. Dr. Dixon’s tenure at UNMC began in 1998 when he joined the Eppley Institute for Research in Cancer and Allied Diseases and focused in the areas of molecular biology, genetics, and biochemistry. 

In 2003, he joined the UNMC technology transfer office and began working with researchers to protect and develop new technology. 

As an active member of the community, he serves on several Boards, including the Board of Directors for Invest Nebraska, non-profit, venture development organization that advises and invests in companies and early-stage business ideas in Nebraska and Bio Nebraska, a nonprofit trade association dedicated to the development and growth of Nebraska’s bioscience industry.